You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • FRI0444 Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Study (Digit)

Article metrics

Article menu
Download PDFPDF
Poster Presentations
Scleroderma, myositis and related syndromes - clinical aspects and treatment
FRI0444 Riociguat for the Treatment of Raynaud's Phenomenon: A Single-Dose, Double-Blind, Randomized, Placebo-Controlled Cross-Over Study (Digit)

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 2015800
Jul 2015400
Aug 2015802
Sep 20151804
Oct 2015801
Nov 20151502
Dec 2015601
Jan 20161904
Feb 20162100
Mar 20161502
Apr 20161501
May 20161300
Jun 20161500
Jul 2016700
Aug 2016800
Sep 20161801
Oct 20161101
Nov 2016601
Dec 20161202
Jan 2017600
Feb 20171200
Mar 20172100
Apr 2017400
May 20171400
Jun 20171703
Jul 20172403
Aug 20173200
Sep 20172400
Oct 20171201
Nov 20171200
Dec 20171401
Jan 20182600
Feb 20181603
Mar 20182602
Apr 20181001
May 20181600
Jun 2018800
Jul 20181200
Aug 20181400
Sep 2018600
Oct 20181000
Nov 20182201
Dec 20182200
Jan 2019600
Feb 2019200
Mar 2019600
Apr 2019200
May 2019801
Jun 2019401
Jul 2019400
Sep 2019400
Oct 20192600
Nov 2019300
Dec 20191700
Jan 20201400
Feb 2020400
Mar 2020300
May 20201300
Jun 2020600
Jul 20201400
Aug 2020400
Sep 20202300
Oct 20201100
Nov 2020600
Dec 2020600
Jan 2021600
Feb 2021200
Apr 2021400
May 2021001
Jun 2021100
Aug 2021300
Oct 2021300
Nov 2021801
Dec 2021600
Jan 2022100
Feb 2022400
Mar 2022500
Apr 20222302
May 20221900
Jun 2022400
Jul 20221400
Aug 20221700
Sep 2022700
Oct 2022900
Nov 2022400
Dec 20221400
Jan 20231301
Feb 2023800
Mar 2023800
Apr 2023200
May 2023600
Jun 2023300
Jul 2023900
Sep 2023600
Oct 2023100
Nov 2023700
Dec 2023800
Jan 20241003
Feb 2024600
Mar 2024800
Total1042047